Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis
Year: 2022
Type: article
Abstract: Tissue injury triggers activation of mesenchymal lineage cells into wound-repairing myofibroblasts, whose unrestrained activity leads to fibrosis. Although this process is largely controlled at the transcriptional level, whether the main transcription factors involved have all been identified has remained elusive. Here, we report multi-omics analyses unraveling Basonuclin 2 (BNC2) as a myofibroblast identity transcription factor. Using liver fibrosis as a model for in-depth investigations, we first show that BNC2 expression is induced in both mouse and human fibrotic livers from different etiologies and decreases upon human liver fibrosis regression. Importantly, we found that BNC2 transcriptional induction is a specific feature of myofibroblastic activation in fibrotic tissues. Mechanistically, BNC2 expression and activities allow to integrate pro-fibrotic stimuli, including TGFβ and Hippo/YAP1 signaling, towards induction of matrisome genes such as those encoding type I collagen. As a consequence, Bnc2 deficiency blunts collagen deposition in livers of mice fed a fibrogenic diet. Additionally, our work establishes BNC2 as potentially druggable since we identified the thalidomide derivative CC-885 as a BNC2 inhibitor. Altogether, we propose that BNC2 is a transcription factor involved in canonical pathways driving myofibroblastic activation in fibrosis.
Source: Nature Communications
Authors: Marie Bobowski-Gerard(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – review & editing), Clémence Boulet(Investigation, Methodology, Validation, Visualization), Francesco P. Zummo(Conceptualization, Investigation, Methodology, Visualization), Julie Dubois-Chevalier(Data curation, Formal analysis, Investigation, Methodology, Software, Validation), Céline Gheeraert, Mohamed Bou Saleh(Investigation, Methodology), Jean-Marc Strub(Investigation, Methodology), Amaury Farce(Investigation, Methodology, Visualization), Maheul Ploton(Investigation, Methodology), Loïc Guille(Resources), Jimmy Vandel(Investigation, Methodology, Software), Antonino Bongiovanni, Ninon Very(Investigation), Eloïse Woitrain(Investigation), Audrey Deprince(Investigation), Fanny Lalloyer, Eric Bauge(Investigation), Lise Ferri(Methodology), Line-Carolle Ntandja-Wandji(Methodology), Alexia K. Cotte(Investigation), Corinne Grangette, Emmanuelle Vallez(Investigation), Sarah Cianférani(Resources), Violeta Raverdy(Resources), Robert Caiazzo(Resources), Viviane Gnemmi(Resources), Emmanuelle Leteurtre(Resources), Benoit Pourcet(Methodology), Réjane Paumelle(Investigation), Kim Ravnskjaer(Investigation, Software, Visualization), Guillaume Lassailly(Methodology, Software, Visualization), Joel T. Haas(Investigation, Methodology), Philippe Mathurin(Resources), François Pattou(Conceptualization, Resources), Laurent Dubuquoy(Conceptualization, Resources), Bart Staels(Conceptualization, Funding acquisition, Project administration), Philippe Lefebvre(Conceptualization, Funding acquisition, Project administration), Jérôme Eeckhoute(Conceptualization, Data curation, Formal analysis, Funding acquisition, Project administration, Visualization, Writing – review & editing)
Institutions: Inserm, Université de Lille, Institut Pasteur de Lille, Centre Hospitalier Universitaire de Lille, Institute for Translational Research in Inflammation, Centre National de la Recherche Scientifique, Institut Pluridisciplinaire Hubert Curien, Plateformes Lilloises en Biologie et Santé, Center for Infection and Immunity of Lille, European Genomic Institute for Diabetes, Recherche translationnelle sur le diabète et les troubles métaboliques, University of Southern Denmark
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,273
Awards: G1185957321, G1502922282, G191178678, G195474297, G2409922865, G3842190047, G4022842478, Metabolic Activation of Dendritic Cells in Non-Alcoholic Steatohepatitis, EGID Diabetes Pole, G474489264, G5605099691, Identification and functional characterization of an unforeseen novel transcription factor controlling hepatic stellate cell activation and liver fibrosis, G6453486480, G7010305552, ULNE, G7376787254, G7636545867, Targeting cellular MEchanisms of altered regeneration for ALcoholic hepatitis precision medicine., PreciNASH, G8429337512, Therapeutic role of cresol producing bacteria in diabetes mellitus
OpenAlex ID: W4295127508
